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Abstract: We report a case where acute onset cortical blindness is the mode of 
presentation in Moyamoya disease.  Cortical blindness is very rare presenting symptom 
of Moyamoya disease. Progressive visual loss and homonymous anopsia has been 
described previously, but this case had acute visual loss. 
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Introduction 
Moyamoya disease is a rare progressive 
vasoocclusive disorder of an unknown 
etiology. It is characterized by progressive 
stenosis of terminal portions of internal 
carotid arteries bilaterally, and the main 
trunks of Anterior and Middle Cerebral 
Artery, and is associated with collateral vessels 
at the base of the brain ('Moyamoya' vessels). 
The term Moyamoya is a Japanese word which 
means “a puff of smoke”. It was coined by 
Suzuki and Takaku in 1969 to describe the 
angiographic appearance of the collateral 
vessels at the base of brain in a group of 21 
patients with internal carotid arterial 
occlusion. (16) 
The histopathology of the affected arteries 
demonstrate a fibrocellular thickening of the 
intima, proliferated smooth muscle cells, 
prominently tortuous and often duplicates 
internal elastic lamina, with no inflammatory 
or atheromatous involvement. (18) 
Moyamoya disease can present as 
progressive visual loss and homonymous 
anopsia which has been described previously. 
(14, 15) 
Case Report 
A 12 year old girl admitted to our 
department had history of loss of vision in 
both eyes within 3 hours. The vision improved 
slightly after 10 days with perception of hand 
movements at 1 foot. Brain CT showed small 
multiple infarcts and large bilateral parieto-
occipital lobe infarcts (Figure 1a) and brain 
T2W MRI showed flow voids around 
midbrain (1b).  
 Cerebral digital substraction angiography 
revealed occlusion of both supraclinoid 
internal carotid artery (Figures 2a and 2b) with 
collateral circulation from multiple enlarged 
lenticulostriate (Figure 2c) and 
thalamoperforating arteries (Figure 2d) 
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suggestive of Moyamoya disease. The detailed 
laboratory workup did not reveal any cause of 
progressive arteriopathy. Cortical blindness is 
very rare presenting symptom of Moyamoya 
disease. Moyamoya disease can present as 
progressive visual loss and homonymous 
anopsia which has been described previously, 
but this case had acute visual loss. 
 
 
Figure 1 - Brain CT shows bilateral parieto-occipital 
lobe infarcts (1a). Brain MRI shows flow voids 
around midbrain (1b) 
 
 
 
Figure 2 - Cerebral digital substraction angiography 
revealed occlusion of both supraclinoid internal 
carotid artery (2a & 2b) with collateral circulation 
from multiple enlarged lenticulostriate (2c) and 
thalamoperforating arteries (2d) suggestive of 
Moyamoya disease 
Discussion  
Moyamoya disease, first described by 
Takeuchi and Shimizu, is a rare 
cerebrovascular condition characterized by 
progressive stenosis of bilateral internal 
carotid arteries with compensatory formation 
of extensive collateral circulation by the dural, 
leptomeningeal and other perforating blood 
vessels giving rise to the typical “a puff of 
smoke” appearance in angiogram (17).  
Moyamoya disease is reported to primarily 
present at an early age, typically less than 10 
years, and is more common in females (M:F 
1:1.8). However, a second peak in the fourth 
decade has also been described in the 
literature. (10) Etiology of Moyamoya disease 
is controversial. Even though several linkage 
studies have shown promising relations with 
gene loci (7, 8), no specific locus has yet been 
identified. However, these linkage studies, 
along with the familial occurrence of 
Moyamoya, point towards a probable genetic 
basis underlying its etiology. Investigations 
into understanding the pathogenesis of 
Moyamoya disease have shown involvement 
of the CSF basic Fibroblast growth factor with 
receptor up regulation, and TGF beta 1 in 
altering the cerebral vasculature (2, 4, 12). 
Intimal thickening has also been postulated 
resulting from altered permeability owing to 
enhanced prostaglandin release from the 
arterial smooth muscle. (19) 
The clinical features of patients with 
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Moyamoya disease reflect the anatomic 
territory of the brain affected by the diseased 
vessel. Yamaguchi et al. in the Annual Report 
for the special working group of Welfare 
Ministry for Moyamoya in 1979 described four 
major types of Moyamoya disease according to 
clinical manifestations; the hemorrhagic type, 
the infarction type, TIA type, and epileptic 
type; with the first two types being the most 
common. (11)   
Despite the reported risks associated with 
conventional angiography (5), it is still 
considered the gold standard for diagnosing 
Moyamoya disease. MR angiography proved 
to be a helpful diagnostic tool identifying sites 
of stenosis and demonstrating the collateral 
vessels at the base of the brain. As a 
noninvasive procedure, it has been described 
in the literature as a promising alternative to 
classical angiography for this arterial disease 
(16).   
Irrespective of the radiological method 
used for diagnosis, conditions like von 
Recklinghausen's disease, Down's syndrome, 
autoimmune vasculitis, head trauma, 
meningitis and brain tumors may have a 
similar angiographic picture and hence can 
possibly confuse the diagnosis. Also, 
postpartum cerebral angiopathy and 
inflammatory angiopathy are two important 
differential diagnoses that may present with 
cerebral ischemia and imaging consistent with 
intracranial vasculopathy mimicking 
Moyamoya disease. (9, 13) 
Four types of surgical procedures have 
been described indirect procedures including 
encephaloduroarteriomyosynangiosis, direct 
revascularization via the superficial temporal 
artery and the middle cerebral artery bypass, 
combined approaches and rarely, denervation 
of cerebral vasculature. In general, pediatric 
cases benefit from indirect revascularization 
procedures and the direct bypass is useful in 
most of adult cases. (6) 
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